Cardiovascular Events in GnRH Agonist vs. Antagonist

PHASE2UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 17, 2020

Primary Completion Date

January 17, 2023

Study Completion Date

January 17, 2023

Conditions
Hormone Sensitive Prostate CancerProstate CancerCardiac Event
Interventions
DRUG

Degarelix

Treatment will start with two injections of 120 mg each followed by maintenance of a single injection of 80 mg administered every 28 days

DRUG

GnRH agonist

GnRH agonist at the discretion of the treating Urologist/Oncologist for 1 year

Trial Locations (1)

4941492

Rabin Medical Center - Beilinson Hospital, Petah Tikva

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Rabin Medical Center

OTHER